Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Nardoni

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Scientific Reports|July 30, 2024
Evidence for faulting and fluid-driven earthquake processes from seismic attenuation variations beneath metropolitan Los AngelesChiara Nardoni, Patricia Persaud
Forensic Sciences Research|November 29, 2018
A facial reconstruction method based on new mesh deformation techniquesMaya de Buhan, Chiara Nardoni
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 15, 2010
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II studyAntonio Rozzi, Chiara Nardoni, Michela Corona, et al.
Genes & Development|April 28, 2017
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiationLucia Latella, Alessandra Dall'Agnese, Francesca Sesillo Boscolo, et al.
Anticancer Research|May 25, 2004
Alfa-epoietin and anaemia in gynaecological cancerBarbara Di Cocco, Nello Salesi, Alessandra Fabi, et al.
Anticancer Research|August 17, 2005
Nail disorders in a woman treated with ixabepilone for metastatic breast cancerAndrea Alimonti, Chiara Nardoni, Paola Papaldo, et al.
Medical Oncology (Northwood, London, England)|January 12, 2013
Pegylated liposomal doxorubicin as third-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II studyAntonio Rozzi, Daniele Santini, Margherita Salerno, et al.
Anticancer Research|July 28, 2004
Epirubicin plus docetaxel in metastatic breast cancer: escalating dose does not improve efficacy. A phase II studyAlessandra Fabi, Paola Papaldo, Maria Simona Pino, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Scientific Reports|July 30, 2024
Evidence for faulting and fluid-driven earthquake processes from seismic attenuation variations beneath metropolitan Los AngelesChiara Nardoni, Patricia Persaud
Forensic Sciences Research|November 29, 2018
A facial reconstruction method based on new mesh deformation techniquesMaya de Buhan, Chiara Nardoni
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 15, 2010
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II studyAntonio Rozzi, Chiara Nardoni, Michela Corona, et al.
Genes & Development|April 28, 2017
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiationLucia Latella, Alessandra Dall'Agnese, Francesca Sesillo Boscolo, et al.
Anticancer Research|May 25, 2004
Alfa-epoietin and anaemia in gynaecological cancerBarbara Di Cocco, Nello Salesi, Alessandra Fabi, et al.
Anticancer Research|August 17, 2005
Nail disorders in a woman treated with ixabepilone for metastatic breast cancerAndrea Alimonti, Chiara Nardoni, Paola Papaldo, et al.
Medical Oncology (Northwood, London, England)|January 12, 2013
Pegylated liposomal doxorubicin as third-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II studyAntonio Rozzi, Daniele Santini, Margherita Salerno, et al.
Anticancer Research|July 28, 2004
Epirubicin plus docetaxel in metastatic breast cancer: escalating dose does not improve efficacy. A phase II studyAlessandra Fabi, Paola Papaldo, Maria Simona Pino, et al.
Pageof 1